Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses.
Saved in:
| Title: | Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses. |
|---|---|
| Authors: | Saba, C. F.1 (AUTHOR) saba2th@yahoo.com, Vickery, K. R.2 (AUTHOR), Clifford, C. A.2 (AUTHOR), Burgess, K. E.3 (AUTHOR), Phillips, B.4 (AUTHOR), Vail, D. M.5 (AUTHOR), Wright, Z. M.6 (AUTHOR), Morges, M. A.7 (AUTHOR), Fan, T. M.8 (AUTHOR), Thamm, D. H.9 (AUTHOR) |
| Source: | Veterinary & Comparative Oncology. Mar2018, Vol. 16 Issue 1, pE76-E82. 7p. 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
